168 related articles for article (PubMed ID: 29509975)
1. Tumour growth rate of follicular thyroid carcinoma is not different from that of follicular adenoma.
Kim M; Han M; Lee JH; Song DE; Kim K; Baek JH; Shong YK; Kim WG
Clin Endocrinol (Oxf); 2018 Jun; 88(6):936-942. PubMed ID: 29509975
[TBL] [Abstract][Full Text] [Related]
2. Is an Increase in Thyroid Nodule Volume a Risk Factor for Malignancy?
Nakamura H; Hirokawa M; Ota H; Kihara M; Miya A; Miyauchi A
Thyroid; 2015 Jul; 25(7):804-11. PubMed ID: 25872408
[TBL] [Abstract][Full Text] [Related]
3. Preoperative serum thyroglobulin and changes in serum thyroglobulin during TSH suppression independently predict follicular thyroid carcinoma in thyroid nodules with a cytological diagnosis of follicular lesion.
Kim HJ; Mok JO; Kim CH; Kim YJ; Kim SJ; Park HK; Byun DW; Suh K; Yoo MH
Endocr Res; 2017 May; 42(2):154-162. PubMed ID: 27936964
[TBL] [Abstract][Full Text] [Related]
4. Ultrasonographic features for differentiating follicular thyroid carcinoma and follicular adenoma.
Kuo TC; Wu MH; Chen KY; Hsieh MS; Chen A; Chen CN
Asian J Surg; 2020 Jan; 43(1):339-346. PubMed ID: 31182260
[TBL] [Abstract][Full Text] [Related]
5. Combined clinical, thyroid ultrasound and cytological features help to predict thyroid malignancy in follicular and Hupsilonrthle cell thyroid lesions: results from a series of 505 consecutive patients.
Rago T; Di Coscio G; Basolo F; Scutari M; Elisei R; Berti P; Miccoli P; Romani R; Faviana P; Pinchera A; Vitti P
Clin Endocrinol (Oxf); 2007 Jan; 66(1):13-20. PubMed ID: 17201796
[TBL] [Abstract][Full Text] [Related]
6. Risk Stratification of Thyroid Nodules With Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance (AUS/FLUS) Cytology Using Ultrasonography Patterns Defined by the 2015 ATA Guidelines.
Lee JH; Han K; Kim EK; Moon HJ; Yoon JH; Park VY; Kwak JY
Ann Otol Rhinol Laryngol; 2017 Sep; 126(9):625-633. PubMed ID: 28719972
[TBL] [Abstract][Full Text] [Related]
7. Ultrasound features and risk stratification system in NIFT-P and other follicular-patterned thyroid tumors.
Matrone A; Gambale C; Pieroni E; De Napoli L; Torregrossa L; Materazzi G; Elisei R
Eur J Endocrinol; 2023 Aug; 189(2):175-182. PubMed ID: 37530386
[TBL] [Abstract][Full Text] [Related]
8. Ultrasonographic features associated with malignancy in cytologically indeterminate thyroid nodules.
Batawil N; Alkordy T
Eur J Surg Oncol; 2014 Feb; 40(2):182-6. PubMed ID: 24373298
[TBL] [Abstract][Full Text] [Related]
9. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of fine needle aspiration biopsy cytology and ultrasonography in patients with thyroid nodules diagnosed as benign or indeterminate before thyroidectomy.
Sugino K; Ito K; Nagahama M; Kitagawa W; Shibuya H; Ohkuwa K; Yano Y; Uruno T; Akaishi J; Suzuki A; Masaki C; Ito K
Endocr J; 2013; 60(3):375-82. PubMed ID: 23197046
[TBL] [Abstract][Full Text] [Related]
11. The impact of thyroid nodule size on the risk of malignancy in follicular neoplasms.
Ibrahim Y; Mohamed SE; Deniwar A; Al-Qurayshi ZH; Khan AN; Moroz K; Friedlander P; Kandil E
Anticancer Res; 2015 Mar; 35(3):1635-9. PubMed ID: 25750321
[TBL] [Abstract][Full Text] [Related]
12. Comparison of malignancy rate in thyroid nodules with cytology of indeterminate follicular or indeterminate Hürthle cell neoplasm.
Sorrenti S; Trimboli P; Catania A; Ulisse S; De Antoni E; D'Armiento M
Thyroid; 2009 Apr; 19(4):355-60. PubMed ID: 19355826
[TBL] [Abstract][Full Text] [Related]
13. Determining Whether Tumor Volume Doubling Time and Growth Rate Can Predict Malignancy After Delayed Diagnostic Surgery of Follicular Neoplasm.
Kim M; Chung SR; Jeon MJ; Han M; Lee JH; Song DE; Baek JH; Kim TY; Kim WB; Shong YK; Kim WG
Thyroid; 2019 Oct; 29(10):1418-1424. PubMed ID: 31375058
[No Abstract] [Full Text] [Related]
14. Expression and clinicopathological role of miR146a in thyroid follicular carcinoma.
Pignatti E; Vighi E; Magnani E; Kara E; Roncati L; Maiorana A; Santi D; Madeo B; Cioni K; Carani C; Rochira V; Simoni M; Brigante G
Endocrine; 2019 Jun; 64(3):575-583. PubMed ID: 30701447
[TBL] [Abstract][Full Text] [Related]
15. Thyroid follicular carcinoma: sonographic features of 50 cases.
Sillery JC; Reading CC; Charboneau JW; Henrichsen TL; Hay ID; Mandrekar JN
AJR Am J Roentgenol; 2010 Jan; 194(1):44-54. PubMed ID: 20028904
[TBL] [Abstract][Full Text] [Related]
16. The natural history of the benign thyroid nodule: what is the appropriate follow-up strategy?
Ajmal S; Rapoport S; Ramirez Batlle H; Mazzaglia PJ
J Am Coll Surg; 2015 Jun; 220(6):987-92. PubMed ID: 25667137
[TBL] [Abstract][Full Text] [Related]
17. Malignancy risk assessment in adenomatoid nodules and suspicious follicular lesions of the thyroid obtained by fine needle aspiration cytology.
Dabelić N; Matesa N; Matesa-Anić D; Kusić Z
Coll Antropol; 2010 Jun; 34(2):349-54. PubMed ID: 20698101
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a preoperative prediction model for follicular thyroid carcinoma.
Yu Q; Liu K; Xie C; Ma D; Wu Y; Jiang H; Dai W
Clin Endocrinol (Oxf); 2019 Aug; 91(2):348-355. PubMed ID: 31050007
[TBL] [Abstract][Full Text] [Related]
19. A risk model to determine surgical treatment in patients with thyroid nodules with indeterminate cytology.
Macias CA; Arumugam D; Arlow RL; Eng OS; Lu SE; Javidian P; Davidov T; Trooskin SZ
Ann Surg Oncol; 2015 May; 22(5):1527-32. PubMed ID: 25388058
[TBL] [Abstract][Full Text] [Related]
20. Qualifiers of atypia in the cytologic diagnosis of thyroid nodules are associated with different Afirma gene expression classifier results and clinical outcomes.
Baca SC; Wong KS; Strickland KC; Heller HT; Kim MI; Barletta JA; Cibas ES; Krane JF; Marqusee E; Angell TE
Cancer Cytopathol; 2017 May; 125(5):313-322. PubMed ID: 28152275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
